The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Are there treatment options for people who are at high-risk of severe illness from COVID-19?
There are treatment options for people who are at high-risk of severe illness from COVID-19. Learn more about the treatment options on the State of Michigan's COVID-19 Therapeutics page.
Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system's attack on cells. Monoclonal antibodies are designed to block viral attachment and entry into human cells, thus neutralizing the virus. When administered to non-hospitalized patients as soon as possible after positive viral testing for SARS-CoV-2 and within 10 days of symptom onset, monoclonal antibodies may reduce viral load, symptoms, and risk of hospitalizations and emergency room visits associated with COVID-19.
Talk to your doctor about whether you should get antibody treatment and where to get it. Providers or patients needing assistance locating an infusion site or connecting with a clinical trial, call the Monoclonal Antibody Therapy Call Center: English: 877-332-6585 | Spanish: 877-366-0310